RMD
ResMed Inc
NYSE: RMD · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$207.81
-0.77% today
Updated 2026-05-05
Market cap
$29.87B
P/E ratio
19.77
P/S ratio
5.39x
EPS (TTM)
$10.37
Dividend yield
1.09%
52W range
$199 – $292
Volume
1.1M
WallStSmart proprietary scores
73
out of 100
Grade: B
Buy
Investment rating
6.7
Growth
B8.3
Quality
A9.5
Profitability
A+5.3
Valuation
C+6/9
Piotroski F-Score
Moderate
4.3
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →198 stocks currently score above 75
Price targets
Analyst target
$270.60
+30.22%
12-Month target
$228.51
+9.96%
Intrinsic (DCF)
$228.75
Margin of safety
-13.50%
3 Strong Buy7 Buy7 Hold1 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 4.34 — safe zone
+ Profit margin 27.40% — above average
+ ROE 25.30% — strong efficiency
+ Free cash flow $520.48M — positive
+ Revenue growth 10.80% QoQ
Risks
- 13.50% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $3.58B | $4.22B | $4.69B | $5.15B | $5.54B | $5.7B |
| Net income | $779.44M | $897.56M | $1.02B | $1.40B | $398.73M | — |
| EPS | — | — | — | — | $10.37 | $11.12 |
| Free cash flow | $195.11M | $559.30M | $1.29B | $1.66B | $520.48M | — |
| Profit margin | 21.78% | 21.25% | 21.79% | 27.22% | 27.40% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-07 | FARRELL, MICHAEL J. | Buy | 4,991 | $146.34 |
| 2026-04-07 | FARRELL, MICHAEL J. | Sale | 4,991 | — |
| 2026-04-01 | SANDERCOCK, BRETT | Sale | 1,000 | $224.31 |
Peer comparison
Smart narrative
ResMed Inc trades at $207.81. representing a P/E of 19.77x trailing earnings. Our Smart Value Score of 73/100 indicates the stock is good. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of 4.34, it sits in the safe zone. TTM revenue stands at $5.54B. with profit margins at 27.40%. Our DCF model estimates intrinsic value at $228.75.
Frequently asked questions
What is ResMed Inc's stock price?
ResMed Inc (RMD) trades at $207.81.
Is ResMed Inc overvalued?
Smart Value Score 73/100 (Grade B, Buy). DCF value $228.75.
What is the price target of ResMed Inc (RMD)?
The analyst target price is $270.60, representing +30.2% upside from the current price of $207.81.
What is the intrinsic value of ResMed Inc (RMD)?
Based on our DCF model, intrinsic value is $228.75, a -13.5% margin of safety versus $207.81.
What is the future stock price of RMD by 2030?
Our research-backed model estimates ResMed Inc could reach $627.45 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is ResMed Inc's revenue?
TTM revenue is $5.54B.
Piotroski F-Score?
6/9 — moderate financial health.
Altman Z-Score?
4.34 — safe zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio5.39x
ROE25.30%
Beta0.85
50D MA$232.92
200D MA$255.73
Shares out0.15B
Float0.14B
Short ratio—
Avg volume1.1M
Performance
1 week-1.94%
1 month-7.61%
3 months-20.99%
YTD-13.73%
1 year—
3 years—
5 years—